NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 86 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2015. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $233,000 | +50.3% | 23,500 | +11.9% | 0.00% | 0.0% |
| Q1 2015 | $155,000 | -84.6% | 21,000 | -88.8% | 0.00% | -83.3% |
| Q4 2014 | $1,006,000 | +22.8% | 187,950 | +15.5% | 0.01% | +100.0% |
| Q3 2014 | $819,000 | -24.8% | 162,790 | +0.3% | 0.00% | -50.0% |
| Q2 2014 | $1,089,000 | +109.8% | 162,290 | +126.5% | 0.01% | +200.0% |
| Q1 2014 | $519,000 | – | 71,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |